AU2002336842A1 - Hp and apolipoprotein biopolymer markers predictive of alzheimers disease - Google Patents

Hp and apolipoprotein biopolymer markers predictive of alzheimers disease

Info

Publication number
AU2002336842A1
AU2002336842A1 AU2002336842A AU2002336842A AU2002336842A1 AU 2002336842 A1 AU2002336842 A1 AU 2002336842A1 AU 2002336842 A AU2002336842 A AU 2002336842A AU 2002336842 A AU2002336842 A AU 2002336842A AU 2002336842 A1 AU2002336842 A1 AU 2002336842A1
Authority
AU
Australia
Prior art keywords
apolipoprotein
alzheimers disease
biopolymer markers
markers predictive
predictive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002336842A
Inventor
George Jackowski
John Marshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syn X Pharma Inc
Original Assignee
Syn X Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syn X Pharma Inc filed Critical Syn X Pharma Inc
Publication of AU2002336842A1 publication Critical patent/AU2002336842A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N5/00—Analysing materials by weighing, e.g. weighing small particles separated from a gas or liquid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2002336842A 2001-11-23 2002-10-31 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease Abandoned AU2002336842A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99336401A 2001-11-23 2001-11-23
US09/993,364 2001-11-23
PCT/CA2002/001654 WO2003046571A2 (en) 2001-11-23 2002-10-31 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease

Publications (1)

Publication Number Publication Date
AU2002336842A1 true AU2002336842A1 (en) 2003-06-10

Family

ID=25539448

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002336842A Abandoned AU2002336842A1 (en) 2001-11-23 2002-10-31 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease

Country Status (3)

Country Link
JP (1) JP2005510727A (en)
AU (1) AU2002336842A1 (en)
WO (1) WO2003046571A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005101017A1 (en) 2004-04-07 2005-10-27 Genentech, Inc. Mass spectrometry of antibody conjugates
ES2544971T3 (en) 2008-05-13 2015-09-07 Genentech, Inc. Analysis of drug and antibody conjugates by mass spectrometry with affinity capture based on spheres
WO2012155019A1 (en) 2011-05-12 2012-11-15 Genentech, Inc. Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature pepides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797402B1 (en) * 1999-07-15 2004-03-12 Biomerieux Stelhys USE OF A POLYPEPTIDE FOR DETECTING, PREVENTING OR TREATING A CONDITION ASSOCIATED WITH A DEGENERATIVE, NEUROLOGICAL OR AUTOIMMUNE DISEASE

Also Published As

Publication number Publication date
WO2003046571A3 (en) 2004-02-19
JP2005510727A (en) 2005-04-21
WO2003046571A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002258790A1 (en) Novel microarrays and methods of use thereof
AU2002336843A1 (en) Biopolymer markers predictive of alzheimers disease
AU2352601A (en) Computer predictions of molecules
AU2002321549A1 (en) Method of providing information
AU2001273475A1 (en) Coagulator and spinal disk surgery
AU2002336842A1 (en) Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
AU2002335964A1 (en) Ig lambda biopolymer markers predictive of alzheimers disease
AU2002335972A1 (en) Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
AU2002335975A1 (en) Apolipoprotein biopolymer markers predictive of alzheimers disease
AU2001288973A1 (en) Non-genetic based protein disease markers
AU2002335977A1 (en) Protein biopolymer markers predictive of insulin resistance
AU2002336844A1 (en) Protein biopolymer markers predictive of insulin resistance
AU2002335969A1 (en) Complement c3 precursor biopolymer markers predictive of alzheimers disease
AU2002249453A1 (en) Enzyme and snp marker for disease
AU2002335963A1 (en) Protein biopolymer markers predictive of alzheimers disease
AU2002335965A1 (en) Pedf biopolymer markers predictive of alzheimers disease
AU2002335967A1 (en) Protein biopolymer markers predictive of alzheimers disease
AU2002335966A1 (en) Plasma protease c1 biopolymer markers predictive of alzheimers disease
AU2002335971A1 (en) Fibronectin precursor biopolymer marker predictive of alzheimers disease
AU2002336851A1 (en) Hp biopolymer markers predictive of insulin resistance
AU2002336019A1 (en) Apolipoprotein biopolymer markers predictive of type ii diabetes
AU2002336018A1 (en) Protein biopolymer markers predictive of type ii diabetes
AU2001274413A1 (en) Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds
AU2002335968A1 (en) Protein biopolymer markers indicative of a disease state
AU3075202A (en) Compositions and methods for the discovery and selection of biological information

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase